Systematic Review
Accepted on 26 Nov 2025
Comparative Efficacy and Safety of Imrecoxib versus Celecoxib: A Systematic Review and Meta-Analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
- 207 views
Type at least 3 characters
1,831 articles
articles
Original Research
Published on 21 Nov 2025
Carnosine as a protective metabolic mediator in inflammatory lung injury by inhibiting macrophage infiltration and M1-like polarization
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1689575
- 722 views
Original Research
Published on 21 Nov 2025
Ivarmacitinib reduces the need for adding/escalating medications in moderate-to-severe rheumatoid arthritis patients: a post hoc analysis from a phase III trial
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1683508
- 719 views
Systematic Review
Published on 20 Nov 2025
Efficacy of pharmacological interventions and therapeutic exercises for rheumatoid arthritis: a systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1686128
- 1,209 views
Original Research
Published on 20 Nov 2025
Ivarmacitinib improves patient-reported outcomes across multiple domains in patients with active ankylosing spondylitis: a post hoc analysis of a phase II/III trial
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1710434
- 835 views
Review
Published on 12 Nov 2025
Epigenetic programming reshapes innate immune memory: decoding the molecular imprint of gouty inflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1678958
- 1,520 views
Review
Published on 10 Nov 2025
Decoding the heterogeneity of liver-resident macrophages in chronic liver diseases: therapeutic responses to immunomodulatory strategies
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1708240
- 1,151 views
Review
Published on 10 Nov 2025
Recent advances in understanding oxidative stress in sepsis: pathogenic roles and antioxidant therapeutic prospects - a narrative review
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1695992
- 1,229 views
Original Research
Published on 10 Nov 2025
Modulation of TNFα-driven neuroinflammation by Gardenin A: insights from in vitro, in vivo, and in silico studies
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1681403
- 1,672 views
Review
Published on 07 Nov 2025
AMPK signaling in osteoarthritis: from mechanisms to targeted therapeutics
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1681610
- 1,055 views
Systematic Review
Published on 06 Nov 2025
Clinical benefits and complication profile of IL-23 inhibitors in patients with psoriatic arthritis: a systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1669786
- 1,366 views
Original Research
Published on 30 Oct 2025
1-stearoyl-2-arachidonoyl-driven B Cell metabolic dysregulation in chronic rhinosinusitis with nasal polyps: insights from Mendelian randomization and single-cell RNA sequencing
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1719897
- 958 views
Original Research
Published on 28 Oct 2025
Regulation of inflammatory pathways by cannabigerol in the collagen induced arthritis model in rats
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1705962
- 1,386 views
Original Research
Accepted on 27 Oct 2025
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for bimekizumab
in Inflammation Pharmacology
Frontiers in Pharmacology
- 439 views
Systematic Review
Published on 27 Oct 2025
Comparison of multiple doses of corticosteroids in Kawasaki disease: a Bayesian network analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1661380
- 1,975 views
Original Research
Published on 22 Oct 2025
CU06-1004 inhibits the progression of chronic colitis and colitis-associated colorectal cancer by suppressing inflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1684870
- 1,570 views
Original Research
Published on 21 Oct 2025
The selective ERβ agonist AC 186 reduces polyinosinic:polycytidylic acid (poly I:C)-induced inflammatory responses in BEAS-2B lung epithelial cells
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1706638
- 1,185 views
Original Research
Published on 17 Oct 2025
A double layer oral film loaded with doxepin hydrochloride for the treatment of chemotherapy-induced oral mucositis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1673190
- 1,017 views
Opinion
Published on 09 Oct 2025
Potential strategies for combination therapy involving medicines with differential signal transduction regulation effects and the mechanism of action of minocycline in septic neuroinflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1691613
- 1,138 views
Clinical Trial
Published on 07 Oct 2025
Preemptive flurbiprofen axetil for sleep-pain-inflammation modulation after laparoscopic gynecological surgery: a prospective, parallel-group randomized controlled trial
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1659179
- 1,874 views
Correction
Published on 07 Oct 2025
Correction: Anti-inflammatory effect and mechanism of stytontriterpene D on RAW264.7 cells and zebrafish
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1620902
- 554 views
- 2 citations
Original Research
Published on 03 Oct 2025
Decoding monocyte heterogeneity in sepsis: a single-cell apoptotic signature for immune stratification and guiding precision therapy
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1675887
- 3,084 views
Review
Published on 01 Oct 2025
Advances in drug delivery systems for the management of gout and hyperuricemia
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1660890
- 3,587 views
Correction
Published on 01 Oct 2025
Correction: Human adipose mesenchymal stem cell-derived exosomes alleviate fibrosis by restraining ferroptosis in keloids
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1705356
- 2,172 views